WEBULL
News
LOVFF
1.180
NaN%
--
Weekly Report: what happened at LOVFF last week (1124-1128)?
Weekly Report · 6d ago
Cannara Biotech Reports Record Fiscal Year 2025
TipRanks · 11/25 03:55
Cannara Biotech Achieves Record Fiscal 2025 Performance and Market Expansion
TipRanks · 11/24 12:44
Cannara Biotech reports FY25 EPS C$0.14 vs. C$0.07 last year
TipRanks · 11/24 12:20
Cannabis firm Cannara Biotech's Q4 revenue rises on market expansion
Reuters · 11/24 12:11
Cannara Biotech GAAP EPS of C$0.04, revenue of C$28.3M
Seeking Alpha · 11/24 12:06
BRIEF-Cannara Biotech Q4 EPS CAD 0.04
Reuters · 11/24 12:00
CANNARA BIOTECH DELIVERS RECORD FISCAL 2025 REVENUE AND PROFITABILITY, ACHIEVES FIRST YEAR OF POSITIVE RETAINED EARNINGS
Reuters · 11/24 12:00
Weekly Report: what happened at LOVFF last week (1117-1121)?
Weekly Report · 11/24 10:34
Cannara Biotech to Release Financial Results and Mourns Board Member’s Passing
TipRanks · 11/17 12:45
CANNARA BIOTECH INC. TO ANNOUNCE FISCAL Q4 2025 AND FISCAL YEAR 2025 FINANCIAL RESULTS ON NOVEMBER 24, 2025 AND PROVIDES BOARD UPDATE
Reuters · 11/17 12:00
Weekly Report: what happened at LOVFF last week (1110-1114)?
Weekly Report · 11/17 10:35
Weekly Report: what happened at LOVFF last week (1103-1107)?
Weekly Report · 11/10 10:32
Weekly Report: what happened at LOVFF last week (1027-1031)?
Weekly Report · 11/03 10:32
Weekly Report: what happened at LOVFF last week (1020-1024)?
Weekly Report · 10/27 10:37
Weekly Report: what happened at LOVFF last week (1013-1017)?
Weekly Report · 10/20 10:32
Weekly Report: what happened at LOVFF last week (1006-1010)?
Weekly Report · 10/13 10:35
Cannara Biotech Expands U.S. Market Access and Strengthens Financial Position
Barchart · 10/08 08:00
Cannara Biotech announces DTC eligibility to facilitate U.S. investor access
TipRanks · 10/07 12:40
More
Webull provides a variety of real-time LOVFF stock news. You can receive the latest news about Cannara Biotech through multiple platforms. This information may help you make smarter investment decisions.
About LOVFF
Cannara Biotech Inc. is a Canada-based vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Canadian markets. The Company operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. It owns two mega cultivation facilities based in Quebec spanning over 1,650,000 square feet and provides up to 100 000 kilograms of annualized cultivation output. It operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations encompass the cultivation, processing and sale of dried cannabis and cannabis derivatives mainly for the Canadian market. The Real estate operations is related to the Farnham and Valleyfield building. The Company's brand portfolio includes Tribal, Nugz, and Orchid CBD. Tribal delivers grade cannabis products. Orchid CBD is a wellness brand that provides CBD-rich cannabis.